Top compounds associated with response to OCLN


Feature Type Standardized
Nominal ANOVA
mRNA nelarabine CTRPv2 pan-cancer AAC -0.014 0.8
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.8
mRNA salermide CTRPv2 pan-cancer AAC -0.017 0.8
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC 0.013 0.8
mRNA Carboplatin CTRPv2 pan-cancer AAC -0.013 0.8
mRNA BRD1835 CTRPv2 pan-cancer AAC -0.013 0.8
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC -0.025 0.8
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.8
mRNA HC-067047 CTRPv2 pan-cancer AAC 0.013 0.8
Download CSV